Medicare Enrolled
Dr. Karin Bigman, M.D.
Medical Oncology · Daytona Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bigman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bigman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bigman
Dr. Karin Bigman is a medical oncology specialist in Daytona Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bigman performed 24,284 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bigman received a total of $2,875 from 58 pharmaceutical and/or device companies across 160 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bigman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 41% volume in FL
$2,875 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗24,284
Medicare services
Top 41% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
19,380 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 2,640 | $18 | $51 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
500 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
440 | $8 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
305 | $91 | $339 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
280 | $10 | $69 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
187 | $1 | $6 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
137 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
97 | $97 | $378 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
58 | $48 | $189 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
54 | $137 | $556 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
42 | $3 | $11 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
38 | $28 | $156 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $138 | $474 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
36 | $22 | $84 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $112 | $453 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
17 | $16 | $59 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
17 | $94 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
80.6% high complexity
13.7% medium
5.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,875
Total received (2018-2024)
Avg $411/year across 7 years
Bottom 35% in FL for medical oncology
58
Companies
160
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$617
2023
$881
2022
$443
2021
$17
2020
$117
2019
$405
2018
$395
Payments by company (2024)
Celgene Corporation
$78
AstraZeneca Pharmaceuticals LP
$56
Incyte Corporation
$46
Eisai Inc.
$43
Merck Sharp & Dohme LLC
$30
Stemline Therapeutics Inc.
$29
BeiGene USA, Inc.
$29
TAIHO ONCOLOGY, INC.
$29
JAZZ PHARMACEUTICALS INC.
$29
EMD Serono, Inc.
$26
ARRAY BIOPHARMA INC
$24
ABBVIE INC.
$22
Daiichi Sankyo Inc.
$22
Astellas Pharma US Inc
$22
Mirati Therapeutics, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
Janssen Biotech, Inc.
$19
Lilly USA, LLC
$19
Gilead Sciences, Inc.
$18
Coherus Biosciences Inc.
$17
Regeneron Healthcare Solutions, Inc.
$16
Top 3 companies account for 29.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$276
Celgene Corporation
$227
BeiGene USA, Inc.
$143
Janssen Biotech, Inc.
$134
Merck Sharp & Dohme Corporation
$123
Incyte Corporation
$120
Eisai Inc.
$114
AstraZeneca Pharmaceuticals LP
$111
Amgen Inc.
$105
Kite Pharma, Inc.
$88
PFIZER INC.
$87
Merck Sharp & Dohme LLC
$67
TAIHO ONCOLOGY, INC.
$61
Ipsen Biopharmaceuticals, Inc
$60
Daiichi Sankyo Inc.
$56
Bayer HealthCare Pharmaceuticals Inc.
$55
EMD Serono, Inc.
$51
Gilead Sciences, Inc.
$51
Foundation Medicine, Inc.
$48
ARRAY BIOPHARMA INC
$40
Seagen Inc.
$38
Lilly USA, LLC
$37
Genentech USA, Inc.
$36
Regeneron Healthcare Solutions, Inc.
$35
Stemline Therapeutics Inc.
$29
JAZZ PHARMACEUTICALS INC.
$29
AMAG Pharmaceuticals, Inc.
$28
Alexion Pharmaceuticals, Inc.
$28
E.R. Squibb & Sons, L.L.C.
$27
Aurobindo Pharma USA, Inc.
$26
MEDIVATION FIELD SOLUTIONS LLC
$26
Rigel Pharmaceuticals, Inc.
$25
NanoString Technologies, Inc.
$24
Pharmacosmos Therapeutics Inc.
$24
Pharmacyclics LLC, An AbbVie Company
$23
SANOFI-AVENTIS U.S. LLC
$23
Lexicon Pharmaceuticals, Inc.
$23
ABBVIE INC.
$22
Astellas Pharma US Inc
$22
Mirati Therapeutics, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
AbbVie Inc.
$21
Seattle Genetics, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Emmaus Medical, Inc.
$18
Exelixis Inc.
$18
TESARO, Inc.
$18
PharmaEssentia USA Corporation
$18
MorphoSys, US Inc.
$18
R-Pharm US LLC
$17
G1 Therapeutics, Inc.
$17
CSL Behring
$17
Coherus Biosciences Inc.
$17
TerSera Therapeutics LLC
$16
Taiho Oncology, Inc.
$14
CTI BioPharma Corp.
$14
Puma Biotechnology, Inc.
$14
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 22.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Afstyla · Avastin · BESREMI · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · COSELA · DARZALEX · ENHERTU · EPKINLY · ERLEADA · Endari · Enhertu · FERAHEME · FOUNDATIONONE · Folotyn · GILOTRIF · Halaven · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Ixempra · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Nubeqa · OPDIVO · OPDUALAG · Onivyde · Orserdu · PIQRAY · PROMACTA · PROSIGNA ASSAY · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · SCEMBLIX · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · TASIGNA · TIVDAK · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Vonjo · XALKORI · XARELTO · XTANDI · Xermelo · Xospata · ZEJULA · ZEPZELCA · Zevalin · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
8
County median income
$66,581
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH DAYTONA BEACH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bigman is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bigman experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Bigman performed 19,380 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bigman receive payments from pharmaceutical companies?
Yes. Dr. Bigman received a total of $2,875 from 58 companies across 160 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bigman's costs compare to other medical oncologists in Daytona Beach?
Dr. Bigman's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bigman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Daytona Beach
Browse medical oncologists in Daytona Beach ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology